Abstract Submission

Instructions for Authors:
Preparing and Submitting an Abstract

General Guidelines

Accepted abstracts will be published in an online supplement issue of Toxicon.  Authors of the accepted abstracts will have the opportunity to submit a PDF of and/or 10-minute presentation(s) of their poster(s) (max 5 slides with audio and/or video – at their own expense) for the Virtual Poster Hall.  The poster presentations will be available on the INA website for 6 months post-conference. 

Encore abstracts are acceptable, but abstract(s) submitted for TOXINS 2021 Virtual Conference cannot be resubmitted for TOXINS 2022 unless the data has been updated.  The poster presentations will be available in the Poster Hall and will not be downloadable.  

Abstracts will be reviewed by the Organizing Committee on a rolling basis until the final abstract submission deadline. Corresponding authors can expect to receive notification regarding the status of their abstract within 6 weeks of submission.

Abstracts must be submitted via the website. Only abstracts submitted via the online submission form will be sent to the Organizing Committee. Abstracts submitted by fax or e-mail will not be accepted.

Abstracts must be submitted in English.

Please contact the Secretariat at info@neurotoxins.org if you submitted an abstract but did not receive confirmation that it had been received.

Submission Checklist

Please ensure the following:

  • Full contact information for the corresponding author and names of the co-authors are provided.
  • The abstract is prepared in English.
  • The character count of the abstract does not exceed 2000 characters including spaces (approximately 500 words). The character count does NOT include author information, title, footer, keywords or financial support. You may submit one chart or figure which is not included in the 2,000-character count. Inclusion in the publication is subject to space limitations.
  • A maximum of 6 keywords is permitted.

Abstracts must be uploaded to this website portal by clicking on the “Submit Abstract” button shown below. The abstract submission deadline date is 12:00 midnight Eastern Daylight Time on Friday, 30 October 2020.

 

Abstracts

The abstract should be concise and factual. Each abstract should briefly state the purpose of the research, the principal results, and major conclusions. Abstracts should be structured as follows:

Format Example for Structured Abstracts (unstructured abstracts will also be accepted)

Title: Bold and all uppercase

John Smitha,*, Jane Doeb
aInstitute/Association, New York, NY; bHospital of Toxins

*Corresponding author: Neurotoxin Institute, 111 North Street, New York, 10004.
E-mail address: john.smith@xxx.com

Abstract title
Titles should be concise, specific, and informative, and should relate to the key points of the work.

Authors’ names and affiliations
Information should include author name, affiliation, city, state, province/region, and country. To specify individual author information, use superscript lower case letters of the alphabet sequentially next to the author’s name and corresponding author information. The author information should appear immediately after the author name listing.

Corresponding author contact information
Information should include: author name, affiliation, e-mail address, mailing address, city, state, province/region, zip/postal code, and country. The corresponding author should be indicated with an asterisk after his/her name in the listing of authors. The corresponding author’s contact information should appear immediately after the line listing the authors’ information.

Introduction
Briefly state the precise objectives of the research or study question and explanatory background.

Methods
Clearly state the experimental methodology. Describe the study setting, basic design of the study, its duration, and the duration of follow-up. State the clinical disorder(s), important eligibility criteria, key sociodemographic features of patients, and number of participants. Explain the interventions (for clinical trials) or exposures (for observational trials).

Results
Results should be clear and concise. The main outcomes of the study should be reported and quantified, including baseline characteristics and final included/analyzed sample, along with confidence intervals or P values.

Conclusions
The main conclusions that are supported by the study should be presented indicating clinical or health policy implications.

Keywords
A maximum of 6 keywords should be provided immediately after the abstract to be used for indexing purposes. General and plural terms and multiple concepts should be avoided. Abbreviations should be used sparingly; only abbreviations firmly established in the field should be used.

Abbreviations
Abbreviations should be defined at their first mention in the text, and should be used consistently throughout the abstract.

Figures
Ensure the illustration has a caption comprising a brief title and a description of the illustration. For pictures or images, accepted formats are jpg, gif, png, and pdf. Picture files should be saved to the smallest file size of acceptable visual quality.

Tables
Tables should be numbered consecutively in accordance with their appearance in the text and should carry a descriptive label.

Figures and tables should be called out next to the relevant text in the manuscript.

References
Every reference cited in the text should also appear in the reference list (and vice versa). You may use author names in your text, as long as these mentions are accompanied by numbered citations. Use last names only. For items with two authors, include both names. For items with 3 or more authors, include the first author’s surname and then ‘et al’ or ‘and colleagues’.

Reference Formatting
In the reference list, references should be arranged first alphabetically and then further sorted chronologically if necessary. More than one reference from the same author(s) in the same year must be identified by the letters ‘a’, ‘b’, ‘c’, etc, placed after the year of publication.

Examples:
Reference to a journal:
Wissel J. Towards flexible and tailored botulinum neurotoxin dosing regimens for focal dystonia and spasticity – insights from recent studies. Toxicon. 2018; 1:147:100-106.

Reference to a book:
Jankovic J, Albanese A, Atassi MZ, Dolly JO, Hallett M, Mayer NH, eds. Botulinum Toxin: Therapeutic Clinical Practice and Science. Philadelphia, PA: Saunders Elsevier;2009.

Reference to a chapter in a book:
Swaminathan S. Molecular structures and functional relationships of botulinum neurotoxins. In: Jankovic J, Albanese A, Atassi MZ, Dolly JO, Hallett M, Mayer NH, eds. Botulinum Toxin: Therapeutic Clinical Practice and Science. Philadelphia, PA: Saunders Elsevier;2009:15-29.

Reference to a website:
American Society for Aesthetic Plastic Surgery, Cosmetic (Aesthetic) Surgery National Data Bank Statistics, 2018. https://www.surgery.org/sites/default/files/ASAPS-Stats2018_0.pdf. Accessed August 1, 2019.

Abbreviations of journal names can be found in PubMed.

Use only standard abbreviations in the text. Place special or unusual abbreviations in parentheses after the full word appears the first time.

Use generic names of drugs. Express numbers as numerals.

Financial support of the research being published should be indicated.

Please see accompanying sample abstract for additional guidance. Submitted abstracts that do not comply with the required format will be returned for proper formatting.

 

Submission Checklist

The following list will be useful during the final checking of an article prior to sending it to the journal for review.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

  • E-mail address
  • Full postal address

All necessary files have been uploaded, and contain:

  • Keywords
  • All figures with captions
  • All tables (including titles)
  • For pictures or images, accepted formats are jpg, gif, png and pdf.

Further considerations

  • The abstract has been “spell-checked” and “grammar-checked”
  • All references mentioned in the reference list are cited in the text and vice versa
  • Permission has been obtained for the use of copyrighted material from other sources (including the Internet)
  • Before you submit your abstract, Name your file by using the” First Author’s” last name, first name (example – Doe, John)

New Abstract Topic

International Forum: Exploring the National, Regional, and Local Clinical Experience With Botulinum Neurotoxins

In recognition of the country-specific and/or institution-specific differences in the use of BoNTs in clinical practice, this session is designed for clinicians and research scientists to share their experience and insights with global colleagues. A session format combining presentations and a panel discussion will identify and explore these differences in the clinical application of BoNTs relating to: patient populations, treatment protocols, best practices for common indications, pharmacoeconomic considerations, and data for the use of BoNT therapy in innovative ways.

You have Successfully Subscribed!

Cancellation policy:

30 days prior to arrival cancelled room nights will be subject to a 100% charge, equivalent to the full value, including any applicable VAT.

You have Successfully Subscribed!

Parking (Focus car park)

We offer the opportunity to pre-book parking in our enclosed section in the nearby Focus car park (Fabriksgatan 45) for 225 SEK/night (valid from 15:00 on the day of your arrival until 13:00 on the day of your departure).

The easiest way to pre-book is when you reserve a room or online via the link you receive in your confirmation or welcome e-mail from us 7 days before your arrival. Alternately, contact the reservations team by e-mail: room@gothiatowers.com or telephone: +46 (0)31-750 88 10.

If you have not pre-booked a parking space or you would like parking after hours, a space may be provided subject to availability. Please contact the Guest Service team at the hotel.

Swedish, Danish, and Norwegian cars:
If you have pre-booked and provided us with your car license number and a mobile phone number, you can drive directly to the Focus car park (Fabriksgatan 45) before checking in.

The car’s license plate will be scanned and the barrier will then open automatically for you at the entrance to the hotel’s enclosed section. The last six digits of your mobile number will be used as a code for the gate when you collect your car.

Cars from other countries, motorcycles, or cars with a personalised license plate:
Our system is unable to read these license plates, and you do not need to provide your license number. Instead, please collect a ticket from Guest Service before driving to the car park.

If you have not pre-booked parking, contact Guest Service when you arrive and they will help you to book a space, subject to availability.

You have Successfully Subscribed!

Group Accommodations Cancellation Policy:

In the event of cancellation of accommodation, the Purchaser may cancel the contracted hotel rooms with no charge up to 180 days prior to arrival.

This is considered the latest allowed date for timely cancellations free of charge. Significant modifications to the booking may result in a re-evaluation of rates and conditions offered.

After this date (180 days) no more than 50% of the reserved rooms per day can be cancelled.

Please note, that in order to cancel the maximum of 50% allowed, the cancellation should occur during period 1 (see below). The original reservation is defined as all rooms (inclusive of VAT) reserved and confirmed on the date stipulated as the last allowed for cancellations.

Period 1: 179-120 days prior to arrival a maximum of 50% of the original reservation per day may be cancelled with no charge.

Period 2: 119-90 days prior to arrival a maximum of 35% of the original reservation per day may be cancelled with no charge.

Example: If a total of 35% or more has already been cancelled during period 1, it will not be possible to make any further changes or reductions without incurring a charge. If, for example, 15% has been cancelled during period 1, it is possible to cancel additional 20% during period 2, so the total cancellation does not exceed 35% of the final reserved event.

Period 3: During the period of 89- 60 days prior to arrival a maximum of 10% of the final reservation per day may be cancelled with no charge.

Example: If a total of 10% or more has already been cancelled during period 1 and 2, it will not be possible to make any further changes or reduction without incurring a charge s. If, for example, 5% has been cancelled during period 1 and 2, it is possible to cancel additional 5% during period 3, so the total cancellation does not exceed 10% of the final reserved event.

Period 4: During the period of 59-20 days prior to arrival a maximum of 5% of the final reservation per day may be cancelled with no charge.

Example: If a total of 5% or more has already been cancelled during period 1, 2 and 3, it will not be possible to make any further changes or reductions without incurring a charge. If, for example, 2% has been cancelled during period 1, 2 and 3, it is possible to cancel additional 3% during period 4, so the total cancellation does not exceed 5% of the final reserved event.

After period 4, cancelled room nights will be subject to a 100% charge, equivalent to the full value, including any applicable VAT.

In the case of no-shows, delayed arrival or early departure the hotel is entitled to payment equivalent to the full price of the original reservation (all nights) as booked.

All changes and amendments by the client have to be confirmed in writing by the Hotel to be validated.

A contract addendum will be sent and should be signed by client for any changes above original contracted room booking.

You have Successfully Subscribed!

Abstract Presentation Note

Awaiting Content

Donec at viverra nulla, eu hendrerit augue. Nam pharetra, diam eget sagittis malesuada, quam purus mollis tellus, in aliquet purus nulla sit amet dui. Fusce eu dolor ultrices, condimentum lorem quis, luctus ante. Nunc ligula erat, mattis a libero ut, finibus porta lectus. In aliquet arcu sed cursus sagittis. Pellentesque vitae pretium urna. Cras sit amet volutpat nunc, eu gravida neque. Vestibulum eu feugiat nulla, eu dignissim lacus. Sed dignissim, lacus et viverra finibus, arcu mi commodo ipsum, interdum faucibus elit turpis sit amet lacus. Maecenas aliquam metus massa, sed commodo enim tempus nec.

You have Successfully Subscribed!

General Guidelines for Abstract Review

Eligible abstracts should present original research on the science of botulinum neurotoxins or their clinical application. Abstracts should be current and of broad interest and importance to those engaged in the field of botulinum neurotoxin research and therapeutics.

Each abstract should be concise and factual. An abstract should briefly state the purpose of the research, the principal results, and major conclusions. Abstracts must be submitted in English.

All abstract(s) should be unbranded; generic names should be used after first mention of product brand names.

Financial support of the research being submitted in the abstract should be indicated if applicable.

Both structured and unstructured abstracts are acceptable. Other (unstructured) abstracts will not follow this format but should contain the same information.

Structured abstracts should be formatted as follows:

• Abstract title
• Authors’ names and affiliations
• Corresponding author contact information

Introduction
This section should briefly state the precise objectives of the research or study question and explanatory background.

Methods
The experimental methodology should be clearly described.

Results
Results should be clear and concise. The main outcomes of the study should be reported and quantified.

Conclusions
The main conclusions that are supported by the study should be presented indicating clinical/research or health policy implications.

You have Successfully Subscribed!

Share This